Date: Tuesday, July 23rd, 2024
Time: 12-1pm PST
Location: Webinar – Online Only
Speaker: Dr. Mark Krailo, Department of Population and Public Health Sciences, University of Southern California and Children’s Oncology Group
About the Speaker: Dr. Mark Krailo is a professor in the Department of Population and Public Health Sciences at the University of Southern California. His primary responsibilities include design and analysis of clinical trials of therapies for children and young adults with cancer. Dr. Krailo is a past member of the Board of Directors of SOCRA.
Objectives:
• Review the process that led to the initial approval of phenylephrine (PE) for use as an OTC oral decongestant.
• Demonstrate how a citizen’s petition resulted in further research and how that research altered the approval status of PE.
SOCRA CEUs available: 1 (for SOCRA members)
Questions: Please contact Allie Mossing (amossing@aligntech.com)
Please RSVP to receive Conference Call Details:
https://aligntech-us00.zoom.us/meeting/register/tJMldeugpzIrEt15EOnOpdnJ55a-Dm5gOwEo